SA519410407B1 - طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول - Google Patents

طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول

Info

Publication number
SA519410407B1
SA519410407B1 SA519410407A SA519410407A SA519410407B1 SA 519410407 B1 SA519410407 B1 SA 519410407B1 SA 519410407 A SA519410407 A SA 519410407A SA 519410407 A SA519410407 A SA 519410407A SA 519410407 B1 SA519410407 B1 SA 519410407B1
Authority
SA
Saudi Arabia
Prior art keywords
methoxypyrrole
preparing intermediate
whole
present
inexpensive
Prior art date
Application number
SA519410407A
Other languages
English (en)
Inventor
- تايك شين جيونج
هيون سون جيونج
تشول لي سيونج
Original Assignee
.دايوونج فارماسوتيكال كو.، ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by .دايوونج فارماسوتيكال كو.، ليمتد filed Critical .دايوونج فارماسوتيكال كو.، ليمتد
Publication of SA519410407B1 publication Critical patent/SA519410407B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بطريقة لتحضير المركبات الوسيطة intermediates الخاصة بمشتقات 4-ميثوكسي بيرول 4-methoxypyrrole. تكون طريقة التحضير وفقًا للاختراع الحالي لديها مميزات حيث يُمكن تقليل تكلفة الإنتاج باستخدام مواد بادئة رخيصة، لا تتطلب تفاعل بدرجة حرارة مرتفعة حيث يتم استخدام مواد كاشفة reagents رخيصة وغير متفجرة كلية بدلًا من (ثلاثي ميثيل سيليل) ثنائي آزو ميثان (trimethylsilyl)diazomethane ، ويُمكن تحضير مركب وسيط أيضًا من مشتقات 4-ميثوكسي بيرول 4-methoxypyrrole ككل بإنتاج مرتفع.
SA519410407A 2017-06-21 2019-10-29 طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول SA519410407B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170078745A KR102233455B1 (ko) 2017-06-21 2017-06-21 4-메톡시피롤 유도체의 중간체 제조 방법

Publications (1)

Publication Number Publication Date
SA519410407B1 true SA519410407B1 (ar) 2022-06-14

Family

ID=64735783

Family Applications (1)

Application Number Title Priority Date Filing Date
SA519410407A SA519410407B1 (ar) 2017-06-21 2019-10-29 طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول

Country Status (30)

Country Link
US (2) US11345660B2 (ar)
EP (1) EP3642181B1 (ar)
JP (1) JP6799178B2 (ar)
KR (1) KR102233455B1 (ar)
CN (1) CN110582482B (ar)
AU (1) AU2018288933B2 (ar)
BR (1) BR112019027323A2 (ar)
CA (1) CA3061713C (ar)
CL (1) CL2019003450A1 (ar)
CO (1) CO2019012689A2 (ar)
DO (1) DOP2019000291A (ar)
EC (1) ECSP19081847A (ar)
ES (1) ES2901701T3 (ar)
HR (1) HRP20211819T1 (ar)
HU (1) HUE057666T2 (ar)
JO (1) JOP20190265B1 (ar)
MA (1) MA49472B1 (ar)
MY (1) MY188800A (ar)
NZ (1) NZ758770A (ar)
PE (1) PE20210151A1 (ar)
PH (1) PH12019502865A1 (ar)
PL (1) PL3642181T3 (ar)
PT (1) PT3642181T (ar)
RS (1) RS62564B1 (ar)
RU (1) RU2737470C1 (ar)
SA (1) SA519410407B1 (ar)
SG (1) SG11201911164WA (ar)
SI (1) SI3642181T1 (ar)
TN (1) TN2019000301A1 (ar)
WO (1) WO2018236153A1 (ar)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
US10789690B2 (en) * 2018-03-07 2020-09-29 Adobe Inc. Masking non-public content
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN109867617A (zh) * 2019-04-03 2019-06-11 南京格亚医药科技有限公司 一种4-甲氧基吡咯中间体的制备方法
CN112094219B (zh) * 2020-09-10 2022-08-05 广东莱佛士制药技术有限公司 一种制备钾离子竞争性阻滞剂中间体的方法
KR20240127136A (ko) * 2023-02-15 2024-08-22 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN117326961B (zh) * 2023-09-27 2024-05-03 安徽峆一药业股份有限公司 一种非苏拉赞中间体的绿色合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622948A (en) 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
ES2402362T3 (es) 2004-09-30 2013-05-03 Takeda Pharmaceutical Company Limited Inhibidores de la bomba de protones
PE20110009A1 (es) 2005-08-30 2011-01-31 Takeda Pharmaceutical Derivados de pirrol como inhibidores de la secrecion acida
JP5248528B2 (ja) 2007-02-02 2013-07-31 エフ．ホフマン−ラ ロシュ アーゲー Ｃｎｓ疾患用のｔａａｒ１リガンドとしての新規２−アミノオキサゾリン
WO2009137657A1 (en) 2008-05-08 2009-11-12 Bristol-Myers Squibb Company 2-aryl glycinamide derivatives
US8895558B2 (en) * 2008-10-02 2014-11-25 Green Cross Corporation Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
KR20170113040A (ko) * 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
WO2017164575A1 (en) 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
KR102081920B1 (ko) * 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102126576B1 (ko) * 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법

Also Published As

Publication number Publication date
CA3061713C (en) 2021-10-12
SI3642181T1 (sl) 2022-04-29
BR112019027323A2 (pt) 2020-07-28
PL3642181T3 (pl) 2022-02-14
SG11201911164WA (en) 2020-01-30
JOP20190265B1 (ar) 2023-03-28
DOP2019000291A (es) 2019-12-15
PH12019502865A1 (en) 2020-12-07
KR102233455B1 (ko) 2021-03-29
HUE057666T2 (hu) 2022-06-28
MY188800A (en) 2022-01-04
US11345660B2 (en) 2022-05-31
WO2018236153A1 (en) 2018-12-27
MA49472B1 (fr) 2022-01-31
RS62564B1 (sr) 2021-12-31
JP2020519680A (ja) 2020-07-02
PT3642181T (pt) 2021-12-20
TN2019000301A1 (en) 2021-05-07
CN110582482A (zh) 2019-12-17
ECSP19081847A (es) 2019-11-30
JOP20190265A1 (ar) 2019-11-12
CA3061713A1 (en) 2018-12-27
EP3642181B1 (en) 2021-11-03
EP3642181A4 (en) 2020-12-09
PE20210151A1 (es) 2021-01-26
AU2018288933A1 (en) 2019-11-21
MA49472A (fr) 2020-04-29
EP3642181A1 (en) 2020-04-29
HRP20211819T1 (hr) 2022-03-04
CN110582482B (zh) 2022-10-11
NZ758770A (en) 2022-01-28
US20220259146A1 (en) 2022-08-18
JP6799178B2 (ja) 2020-12-09
RU2737470C1 (ru) 2020-11-30
CO2019012689A2 (es) 2020-01-17
KR20180138476A (ko) 2018-12-31
ES2901701T3 (es) 2022-03-23
AU2018288933B2 (en) 2020-12-10
US20200181080A1 (en) 2020-06-11
CL2019003450A1 (es) 2020-03-27

Similar Documents

Publication Publication Date Title
SA519410407B1 (ar) طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول
PH12019502638A1 (en) Method for preparing intermediate of 4-methoxypyrrole derivative
MX2018000354A (es) Proceso para la producción de cannabidiol y delta-9-tetrahidrocana binol.
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
NZ718009A (en) Process for producing diazabicyclooctane derivative and intermediate thereof
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
MX2018014130A (es) Procedimiento e intermedios para la 6,7-alfa-epoxidacion de 4,6-dienos esteroideos.
MX2019005319A (es) Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo.
MX2022001495A (es) Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble.
WO2015120111A3 (en) Expedient synthesis of sitagliptin
MX2016001519A (es) Derivados de 25-oh vitamina d para determinacion de metabolitos de vitamina d.
MX2015010934A (es) Metodo para producir un compuesto triciclico, y un compuesto triciclico capaz de producirse por dicho metodo de produccion.
MX2016016730A (es) Metodo para preparar un producto intermedio de eribulina.
MX2018011330A (es) Formas polimorficas de un oxiesterol y metodos para realizarlas.
JOP20180126A1 (ar) عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان
MY165659A (en) Novel method of preparing benzoimidazole derivatives
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
MX2021008323A (es) Preparacion de 5-aril pentanoles.
NZ727773A (en) Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy- cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs
TW201611889A (en) Solid catalyst for dehydration of sugar alcohol and method for preparing dianhydrosugar alcohol using said catalyst
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
JOP20170012B1 (ar) عملية لتخليق مركبات نيبيفولول الوسيطة
WO2015075693A8 (en) Process for the synthesis of (11 beta,17alpha)-17-acetoxy-11 -methyl-19-norpregn-4-en-3,20-dione
WO2019103549A3 (ko) 디메틸테레프탈레이트의 제조방법
MX2015014004A (es) Proceso de producción de fructooligosacáridos a partir de sacarosa mediante el uso de células permeadas de levaduras del género cándida.